dobutamine has been researched along with denopamine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isogaya, M; Kikkawa, H; Kurose, H; Nagao, T; Sugimoto, Y; Tanaka, R; Tanimura, R | 1 |
| Bals, S; Brodde, OE; Deighton, NM; Motomura, S; Zerkowski, HR | 1 |
| Hattori, R; Kawai, C; Sakaguchi, K; Susawa, T; Takatsu, Y; Yui, N; Yui, Y | 1 |
| Ikeo, T; Kikkawa, K; Miyazaki, K; Nagao, T; Narita, H; Yabana, H | 1 |
| Ikeo, T; Murata, S; Nagao, T; Nakajima, H; Sato, M | 1 |
1 trial(s) available for dobutamine and denopamine
| Article | Year |
|---|---|
Hemodynamic effect of oral TA-064 after dobutamine in congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Dobutamine; Ethanolamines; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Time Factors | 1987 |
4 other study(ies) available for dobutamine and denopamine
| Article | Year |
|---|---|
Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alanine; Albuterol; Amino Acid Substitution; Animals; Binding Sites; Computer Simulation; COS Cells; Ethanolamines; Formoterol Fumarate; Humans; Models, Molecular; Norepinephrine; Procaterol; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Recombinant Fusion Proteins; Xamoterol | 1999 |
Characterization of the beta adrenoceptor subtype(s) mediating the positive inotropic effects of epinine, dopamine, dobutamine, denopamine and xamoterol in isolated human right atrium.
Topics: Adrenergic beta-Agonists; Adult; Aged; Calcium; Deoxyepinephrine; Dobutamine; Dopamine; Ethanolamines; Female; Heart Atria; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Propanolamines; Stimulation, Chemical; Xamoterol | 1992 |
Weak arrhythmogenic property of the new cardiotonic agent denopamine in dogs: comparison with catecholamines.
Topics: Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Cardiovascular System; Catecholamines; Dobutamine; Dogs; Ethanolamines; Halothane; Hemodynamics; Isoproterenol | 1986 |
Cardiovascular effects of a new positive inotropic agent, (-)-(R)-1-(p-hydroxyphenyl)-2-[(3,4-dimethoxyphenethyl)amino]-ethanol (TA-064) in the anesthetized dog and isolated guinea pig heart.
Topics: Adrenergic beta-Agonists; Anesthesia; Animals; Blood Pressure; Cardiotonic Agents; Dobutamine; Dogs; Ethanolamines; Femur; Guinea Pigs; Heart; In Vitro Techniques; Male; Myocardial Contraction; Perfusion; Phenylephrine; Regional Blood Flow; Reserpine; Stereoisomerism | 1984 |